2022
DOI: 10.2337/dc23-s015
|View full text |Cite
|
Sign up to set email alerts
|

15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023

Abstract: The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
191
0
13

Year Published

2023
2023
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 187 publications
(204 citation statements)
references
References 140 publications
0
191
0
13
Order By: Relevance
“…Moreover, a history of GDM confers a sevenfold increased risk of T2D in the mother [188][189][190], and a post-partum OGTT and life-long metabolic follow-up are recommended to screen a persistent dysglycemia or a new onset of prediabetes or diabetes, respectively [191]. Furthermore, GDM diagnosed by different criteria (IADSPG vs Carpenter&Coustan) was found differently associated to persistent prediabetes or overt diabetes, being IADSPG criteria less predictive [192].…”
Section: Mothermentioning
confidence: 99%
“…Moreover, a history of GDM confers a sevenfold increased risk of T2D in the mother [188][189][190], and a post-partum OGTT and life-long metabolic follow-up are recommended to screen a persistent dysglycemia or a new onset of prediabetes or diabetes, respectively [191]. Furthermore, GDM diagnosed by different criteria (IADSPG vs Carpenter&Coustan) was found differently associated to persistent prediabetes or overt diabetes, being IADSPG criteria less predictive [192].…”
Section: Mothermentioning
confidence: 99%
“…The islet cells need to make new assessments and adjustments to meet the body’s insulin requirement ( ElSayed et al, 2023a ). Puerperium is the “window phase” of recovery of glucose metabolism in women with GDM, particularly those who were overweight/obese before pregnancy ( ElSayed et al, 2023b ). Thus, the early postnatal period for initiating and sustaining lifestyle changes is the “window period” for recovery of glucose metabolism and islet function in women with GDM, particularly those who were overweight or obese prior to pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the early postnatal period for initiating and sustaining lifestyle changes is the “window period” for recovery of glucose metabolism and islet function in women with GDM, particularly those who were overweight or obese prior to pregnancy. The postpartum period is also crucial for healthcare professionals to offer advice and support to women with GDM, considering that changes in lifestyle (such as a healthy diet and increased physical activity) have been shown to prevent the further development of T2DM ( Aroda et al, 2015 ; ElSayed et al, 2023b ).…”
Section: Introductionmentioning
confidence: 99%
“…Glycemic control can reduce perinatal complications, and blood glucose monitoring is a cornerstone of maintaining optimal blood glucose. Although hemoglobin A1c (HbA1c) levels fall during pregnancy due to physiological increases of red blood cell turnover, guidelines recommend an optimal target of HbA1c<6% during pregnancy without significant hypoglycemia ( 5 ). Additionally, as HbA1c represents an integrated measure of glucose, it may not fully capture postprandial hyperglycemia.…”
Section: Introductionmentioning
confidence: 99%
“…Continuous glucose monitoring (CGM) technologies assess dynamic glucose levels in daily life to measure the duration and magnitude of fluctuation, especially for fasting and postprandial measurements, for 72 h to 14 days ( 7 ). The American Diabetes Association (ADA) suggests that the use of CGM during pregnancy is associated with improved HbA1c levels and neonatal outcomes for pregnant women with type 1 diabetes ( 5 ). However, CGM use in GDM women is controversial.…”
Section: Introductionmentioning
confidence: 99%